Cargando…
GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence
The major goal in the treatment of type 2 diabetes mellitus is to control the hyperglycaemia characteristic of the disease. However, treatment with common therapies such as insulin or insulinotrophic sulphonylureas (SU), while effective in reducing hyperglycaemia, may impose a greater risk of hypogl...
Autores principales: | Meloni, A R, DeYoung, M B, Lowe, C, Parkes, D G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556522/ https://www.ncbi.nlm.nih.gov/pubmed/22776039 http://dx.doi.org/10.1111/j.1463-1326.2012.01663.x |
Ejemplares similares
-
Upregulated insulin secretion in insulin-resistant mice: evidence of increased islet GLP1 receptor levels and GPR119-activated GLP1 secretion
por: Ahlkvist, L, et al.
Publicado: (2013) -
Olfactory receptors are expressed in pancreatic β-cells and promote glucose-stimulated insulin secretion
por: Munakata, Yuichiro, et al.
Publicado: (2018) -
Systematic Synergy of Glucose and GLP-1 to Stimulate Insulin Secretion Revealed by Quantitative Phosphoproteomics
por: Tang, Jia-shu, et al.
Publicado: (2017) -
Mechanisms Controlling Glucose-Induced GLP-1 Secretion in Human Small Intestine
por: Sun, Emily W., et al.
Publicado: (2017) -
The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism
por: Andreozzi, Francesco, et al.
Publicado: (2016)